() Moxiclear spot-on solution | Norbrook
  • Active Ingredient

    Small Cats and Ferrets 

    Each 0.4 pipette contains: 

    • Imidacloprid 40mg 
    • Moxidectin 4 mg

    Medium Cats

    Each 1.0 ml pipette contains: 

    • Imidacloprid 100 mg 
    • Moxidectin 4 mg 

    Large Cats: 

    Each 2.5 ml pipette contains 

    • Imidacloprid 250 mg 
    • Moxidectin 62.5 mg 

    Small Dogs: 

    Each 0.4 ml pipette contains: 

    • Imidacloprid 40 mg 
    • Moxidectin 10 mg 

    Large Dogs: 

    Each 2.5 ml pipette contains: 

    • Imidacloprid 250 mg 
    • Moxidectin 62.5 mg 

    Very Large Dogs: 

    Each 4 ml pipette contains: 

    • Imidacloprid 400 mg 
    • Moxidectin 100 mg  
  • Pharmaceutical Form

    Spot-on solution.
    A clear colourless to yellow solution with light opalescence.

    Moxiclear 40 mg + 4 mg Spot-On Solution for Small Cats and Ferrets. Each 0.4ml pipette contains: 40mg imidacloprid mg and 4mg moxidectin. 
    Moxiclear 80 mg + 8 mg Spot-On Solution for Large Cats. Each 0.8ml pipette contains: 80mg imidacloprid and 8mg moxidectin. 
    Moxiclear 40 mg + 10 mg Spot-On Solution for Small Dogs. Each 0.4ml pipette contains 40mg imidacloprid and 10mg moxidectin. 
    Moxiclear 100 mg + 25 mg Spot-On Solution for Medium Dogs. Each 1.0ml pipette contains 100mg imidacloprid and 25mg moxidectin. 
    Moxiclear 250 mg + 62.5mg Spot-On Solution for Large Dogs. Each 2.5ml pipette contains 250mg imidacloprid and 62.5mg moxidectin. 
    Moxiclear 400 mg + 100 mg Spot-On Solution for Very Large Dogs. Each 4.0ml pipette contains 400mg imidacloprid and 100mg moxidectin. 
  • Indications

    Dogs

    For dogs suffering from, or at risk from, mixed parasitic infections: 

    For the treatment and prevention of flea infestation (Ctenocephalides felis),

    the treatment of biting lice (Trichodectes canis), the treatment of ear mite infestation (Otodectescynotis), sarcoptic mange (caused  by Sarcoptes scabiei var. canis), ,
    the prevention of heart worm disease(L3 andL4 larvae of Dirofilaria immitis),
    the treatment of circulating microfilariae (Dirofilaria immitis),
    the treatment of cutaneous dirofilariosis (adult stages of Dirofilaria repens)
    the prevention of cutaneous dirofilariosis (L3 larvae of Dirofilaria repens),
    the reduction of circulating microfilariae (Dirofilaria repens),
    the prevention of angiostrongylosis(L4 larvae and immature adults of Angiostrongylus vasorum),
    the treatment of Angiostrongylus vasorum and Crenosoma vulpis,
    the prevention of spirocercosis (Spirocerca lupi),
    the treatment of infections with gastrointestinal nematodes (L4 larvae, immature adults and adults of Toxocara canis, Ancylostoma caninum and Uncinaria stenocephala, adults of Toxascaris leonina and Trichuris vulpis).
    The product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).

    Cats 

    For cats suffering from, or at risk from, mixed parasitic infections:


    For the treatment and prevention of flea infestation (Ctenocephalides felis),
    the treatment of ear mite infestation (Otodectes cynotis),
    the treatment of notoedric mange (Notoedres cati),
    the prevention of heartworm disease (L3 and L4 larvae of Dirofilaria immitis),
    the treatment of infections with gastrointestinal nematodes (L4 larvae, immature adults and adults of Toxocara cati and Ancylostoma tubaeforme). The product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).

    Ferrets 

    For ferrets suffering from, or at risk from, mixed parasitic infections:

    For the treatment and prevention of flea infestation (Ctenocephalides felis),
    the prevention of heartworm disease (L3 and L4 larvae of Dirofilaria immitis).

  • Dosage

    Dogs: 

    The recommended minimum doses are 10 mg/kg bodyweight imidacloprid and 2.5 mg/kg bodyweight moxidectin, equivalent to 0.1 ml/kg bodyweight the product for dogs. The treatment schedule should be based on individual veterinary diagnosis and on the local epidemiological situation. 

    Moxiclear Dosing Schedule for Dogs

    Cats: 

    The recommended minimum doses are 10 mg/kg bodyweight imidacloprid and 1.0 mg/kg bodyweight moxidectin, equivalent to 0.1 ml/kg bodyweight of product. The treatment schedule should be based on individual veterinary diagnosis and on the local epidemiological situation. 

    Moxiclear for Cats Dosing Schedule

    Ferrets:

    One pipette of Moxiclear Spot-On Solution for Small Cats (0.4ml) should be administered per animal. Do not exceed the recommended dose. The treatment schedule should be based on the local epidemiological situation. 

     

Prefer to speak directly to a member of our team?

Norbrook GB 

We are open. Mon - Fri 9:00am - 5:00pm

Please note: Product information presented on this website is intended only as a brief summary of Norbrook products for your convenience. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information you should always consult a healthcare professional from your region or visit the local government agency website for the most up to date information. Please see our terms and conditions for further information.